Physiomics PLC IMC Presentation on Board Changes
October 15 2024 - 6:30AM
RNS Non-Regulatory
RNS Number : 2609I
Physiomics PLC
15 October 2024
15 October 2024
Physiomics plc
("Physiomics" or the "Company")
IMC Presentation on Company
Website
Physiomics plc (AIM: PYC), a leading
mathematical modelling, data science and biostatistics company
supporting the development of new therapeutics and personalised
medicine solutions, recently provided a brief update
in-line with its End of Year results via Investor Meet Company and has updated
its website with the presentation.
The presentation and Q&A
from the meeting are now available at the Company's
website:
https://www.physiomics.co.uk/portfolio-item/investor-presentation-full-year-results-and-company-update/
Enquiries:
Physiomics
plc
Dr Jim Millen, Non-Executive
Chairman
Dr Peter Sargent, Chief Executive
Officer
+44 (0)1235 841575
Hybridan LLP
(Broker)
Claire Louise Noyce
+44 (0) 203 764 2341
Strand Hanson
Ltd (NOMAD)
James Dance & James Bellman
+44 (0)20 7409 3494
Notes to
Editor
About Physiomics
Physiomics plc combines expertise
across Modelling & Simulation, Biostatistics, Data Science and
Bioinformatics, together with deep biology expertise, to help
biotech and pharma companies streamline their drug development
journeys. Our approach is to help derive insight from all relevant
and often disparate data in order to de-risk decision making and
optimise research design across discovery, pre-clinical and
clinical studies. Through use of cutting-edge computational tools,
bespoke models and our proprietary Virtual Tumour technology, the
Physiomics team has informed the development of over 100 commercial
projects, with over 125 targets and drugs modelled. Clients include
Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics
& CRUK.
This information is provided by Reach, the non-regulatory
press release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NRAGZMMGGKDGDZM
Physiomics (LSE:PYC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Physiomics (LSE:PYC)
Historical Stock Chart
From Nov 2023 to Nov 2024